Correlation Between Emergent Biosolutions and Instadose Pharma

Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Instadose Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Instadose Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Biosolutions and Instadose Pharma Corp, you can compare the effects of market volatilities on Emergent Biosolutions and Instadose Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Instadose Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Instadose Pharma.

Diversification Opportunities for Emergent Biosolutions and Instadose Pharma

0.0

Correlation Coefficient

Emergent Biosolutions  Instadose Pharma

Pay attention - limited upside

The 3 months correlation between Emergent and Instadose is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Instadose Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instadose Pharma Corp and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Instadose Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instadose Pharma Corp has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Instadose Pharma go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Instadose Pharma

If you would invest  0.11  in Instadose Pharma Corp on December 30, 2024 and sell it today you would earn a total of  0.00  from holding Instadose Pharma Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Emergent Biosolutions  vs.  Instadose Pharma Corp

Emergent Biosolutions

Risk-Adjusted Performance

Very Weak

Over the last 90 days Emergent Biosolutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Instadose Pharma Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Instadose Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Instadose Pharma is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Emergent Biosolutions and Instadose Pharma

The main advantage of trading using opposite Emergent Biosolutions and Instadose Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Instadose Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instadose Pharma will offset losses from the drop in Instadose Pharma's long position.

The idea behind Emergent Biosolutions and Instadose Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.